The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America
-
- Gary P. Wormser
- Divisions of Infectious Diseases and New York University School of Medicine, New York, New York
-
- Raymond J. Dattwyler
- Divisions of Allergy, Immunology, and Rheumatology, Department of Medicine, New York Medical College, Valhalla, and New York University School of Medicine, New York, New York
-
- Eugene D. Shapiro
- Departments of Pediatrics and Department of Pediatrics, University of Connecticut School of Medicine and Connecticut Children's Medical Center, Hartford
-
- John J. Halperin
- Divisions of New York University School of Medicine, New York, New York
-
- Allen C. Steere
- Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, and Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts
-
- Mark S. Klempner
- Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts
-
- Peter J. Krause
- Department of Pediatrics, University of Connecticut School of Medicine and Connecticut Children's Medical Center, Hartford
-
- Johan S. Bakken
- Section of Infectious Diseases, St. Luke's Hospital, Duluth, Minnesota
-
- Franc Strle
- Department of Infectious Diseases, University Medical Center, Ljubljana, Slovenia
-
- Gerold Stanek
- Medical University of Vienna, Vienna, Austria
-
- Linda Bockenstedt
- Departments of Section of Rheumatology, Department of Medicine, Yale University School of Medicine, New Haven, and Department of Pediatrics, University of Connecticut School of Medicine and Connecticut Children's Medical Center, Hartford
-
- Durland Fish
- Departments of Epidemiology and Public Health and Department of Pediatrics, University of Connecticut School of Medicine and Connecticut Children's Medical Center, Hartford
-
- J. Stephen Dumler
- Division of Medical Microbiology, Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland
-
- Robert B. Nadelman
- Divisions of Infectious Diseases and New York University School of Medicine, New York, New York
この論文をさがす
説明
<jats:title>Abstract</jats:title><jats:p>Evidence-based guidelines for the management of patients with Lyme disease, human granulocytic anaplasmosis (formerly known as human granulocytic ehrlichiosis), and babesiosis were prepared by an expert panel of the Infectious Diseases Society of America. These updated guidelines replace the previous treatment guidelines published in 2000 (Clin Infect Dis 2000; 31[Suppl 1]:1–14). The guidelines are intended for use by health care providers who care for patients who either have these infections or may be at risk for them. For each of these Ixodes tickborne infections, information is provided about prevention, epidemiology, clinical manifestations, diagnosis, and treatment. Tables list the doses and durations of antimicrobial therapy recommended for treatment and prevention of Lyme disease and provide a partial list of therapies to be avoided. A definition of post–Lyme disease syndrome is proposed.</jats:p>
収録刊行物
-
- Clinical Infectious Diseases
-
Clinical Infectious Diseases 43 (9), 1089-1134, 2006-11-01
Oxford University Press (OUP)
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1363951793601924096
-
- DOI
- 10.1086/508667
-
- ISSN
- 15376591
- 10584838
-
- データソース種別
-
- Crossref